18 February 2023 : Clinical Research
Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel Disease
Tomislav Jukic1CDEF, David Drobne2ABCDE, Sasa Pusavec3BF, Alojz Ihan3AE, David Stubljar4ACDE*, Andrej Starc5DEDOI: 10.12659/MSM.939084
Med Sci Monit 2023; 29:e939084
Table 4 Comparison of samples between University of Leuven (UHL) test and Lisa-Tracker test: number of samples in a respective group.
| TL IFX <3 μg/mL – UHL | TL IFX=3–7 μg/mL – UHL | TL IFX >7 μg/mL – UHL | |
|---|---|---|---|
| TL IFX | 3 | 0 | 0 |
| TL IFX=3–7 μg/mL – Lisa-Tracker | 1 | 5 | 0 |
| TL IFX >7 μg/mL – Lisa-Tracker | 0 | 5 | 5 |